Gene · 3767
Papers4,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular and Clinical Profiles of Pediatric Monogenic Diabetes Subtypes: Comprehensive Genetic Analysis of 138 Patients. | J Clin Endocrinol Metab | 2025 | 39504571 | PubTator, text mining | PubMed |
| Clinical and Genetic Characteristics of Congenital Hyperinsulinism in Norway: A Nationwide Cohort Study. | J Clin Endocrinol Metab | 2025 | 38963811 | PubTator, text mining | PubMed |
| Diazoxide-unresponsive Hyperinsulinemic Hypoglycaemia in a Preterm Infant with Heterozygous Insulin Receptor Gene Mutation | J Clin Res Pediatr Endocrinol | 2025 | 37074094 | PubTator, text mining | PubMed |
| Incidence, Phenotypes, and Genotypes of Neonatal Diabetes: A 16-Year Experience. The Rare Genetic Etiologies of Neonatal Diabetes Are Common in Sudan. | Pediatr Diabetes | 2024 | 40302952 | PubTator, text mining | PubMed |
| Congenital hyperinsulinism in the Ukraine: a 10-year national study. | Front Endocrinol (Lausanne) | 2024 | 39741883 | PubTator, text mining | PubMed |
| Precision therapy for Developmental delay, Epilepsy and Neonatal Diabetes syndrome in the era of genomics. | Med J Armed Forces India | 2024 | 39734857 | PubTator, text mining | PubMed |
| Challenges in diagnosis and treatment of KCNJ11-MODY. | Endocrinol Diabetes Metab Case Rep | 2024 | 39700334 | PubTator, text mining | PubMed |
| Our Experiences and Learnings in Diagnosing MODY from Non-Institutional-Based Diabetes Care Clinics. | Indian J Endocrinol Metab | 2024 | 39676784 | PubTator, text mining | PubMed |
| Genetic association of type 2 diabetes and antidiabetic drug target with skin cancer. | Front Med (Lausanne) | 2024 | 39640975 | PubTator, text mining | PubMed |
| Genetic Variations in Hyperinsulinemic Hypoglycemia: Active versus Inactive Mutations. | Diabetes Metab Syndr Obes | 2024 | 39619217 | PubTator, text mining | PubMed |
| The impact of site-specific DNA methylation in KCNJ11 promoter on type 2 diabetes. | Heliyon | 2024 | 39584094 | PubTator, text mining | PubMed |
| Potassium inwardly-rectifying channel subfamily J member 11 (KCNJ11) gene polymorphism in Egyptian type 2 diabetic patients: a single-center study. | Mol Biol Rep | 2024 | 39508922 | PubTator, text mining | PubMed |
| Translation of genome-wide association study: from genomic signals to biological insights. | Front Genet | 2024 | 39421299 | PubTator, text mining | PubMed |
| A case series of maturity-onset diabetes of the young highlighting atypical presentations and the implications of genetic diagnosis. | Arch Endocrinol Metab | 2024 | 39420905 | PubTator, text mining | PubMed |
| Description and functional validation of human enteroendocrine cell sensors. | Science | 2024 | 39418382 | PubTator, text mining | PubMed |
| A Proteogenomic Approach to Unveiling the Complex Biology of the Microbiome. | Int J Mol Sci | 2024 | 39408795 | PubTator, text mining | PubMed |
| Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Glibenclamide in a Young Adult With KCNJ11 Permanent Neonatal Diabetes. | Diabetes Care | 2024 | 39403023 | PubTator, text mining | PubMed |
| Characterization of four structurally diverse inhibitors of SUR2-containing KATP channels. | Channels (Austin) | 2024 | 39303216 | PubTator, text mining | PubMed |
| Association Study of CACNA1D, KCNJ11, KCNQ1, and CACNA1E Single-Nucleotide Polymorphisms with Type 2 Diabetes Mellitus. | Int J Mol Sci | 2024 | 39273144 | PubTator, text mining | PubMed |
| Molecular study of the KCNJ11 gene and its correlation with Prakriti to preventing and managing type 2 diabetes. | J Tradit Complement Med | 2024 | 39262659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3767/papers?page=9